Hodgkin

May 12, 2020

Curis Reports First Quarter 2020 Financial Results

May 05, 2020

Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets

Apr 14, 2020

Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma

Feb 27, 2020

Hodgkin Lymphoma Treatment Market Forecasts to 2025 with Alkem Labs, Amneal Pharma, Baxter Int'l, Biogen, BMS, Roche, Incyte Corp, Merck & Co, Seattle Genetics, and Teva Pharma Industries Dominating

Dec 05, 2019

Cancer Treatment Centers of America Continues Pioneering Efforts in Immuno-Oncology; Doses First Patient in Novel Immunotherapy Clinical Trial

Dec 04, 2019

Nordic Nanovector: New preclinical Data Offer Insights Into Enhancing Betalutin®-Based Therapies in NHL

Jul 11, 2019

Non-Hodgkin Lymphoma (NHL) Therapeutics Market to Record a CAGR of 7.4% During 2019-2024

Apr 17, 2019

Global Hodgkin's Lymphoma Drugs Market 2019-2023: Treatment of Hodgkin's Lymphoma Patients with Conjoint Conditions Gaining Momentum

Mar 12, 2019

The hodgkin's lymphoma drugs market will register a CAGR of close to 16% by 2023

Dec 18, 2017

Europe Hodgkin Lymphoma Market and Competitive Landscape 2012-2017 & 2021